{1}

##LOC[OK]##

{1}

##LOC[OK]## ##LOC[Cancel]##

{1}

##LOC[OK]## ##LOC[Cancel]##

Peter Anastasiou CEO Capsida Biotherapeutics

Peter Anastasiou

CEO Capsida Biotherapeutics

Christopher Boerner, PhD Chief Executive Officer Bristol Myers Squibb

Christopher Boerner, PhD

Chief Executive Officer Bristol Myers Squibb

Randall Bradford Executive Vice President, Group Human Resources, Head of Human Resources, Healthcare Merck KGaA, Darmstadt Germany

Randall Bradford

Executive Vice President, Group Human Resources, Head of Human Resources, Healthcare Merck KGaA, Darmstadt Germany

Charles DeWildt Chief Commercial Officer Neurelis, Inc.

Charles DeWildt

Chief Commercial Officer Neurelis, Inc.

Jag Dosanjh President, U.S. Neuroscience and Eye Care AbbVie Inc.

Jag Dosanjh

President, U.S. Neuroscience and Eye Care AbbVie Inc.

Jag Dosanjh is President, U.S. Neuroscience and Eye Care at AbbVie. In this role, he is responsible for leading the commercial business representing a strong portfolio of major brands across many different disease areas. Jag joined Allergan in 2011 and served in a variety of roles with increasing responsibility, including in Aesthetics, managed markets and global strategic marketing, and most recently served as Senior Vice President, Medical Therapeutics, overseeing BOTOX Therapeutic and Eye Care. Prior to this, Jag worked at GlaxoSmithKline for over 15 years in several executive positions in both Europe and United States with key areas of focus being Vaccine biologicals and Respiratory medicine. Jag holds a BA (Hons) degree in Business Studies from Sheffield Hallam University in the UK.

Eric Dube President and CEO Travere Therapeutics

Eric Dube

President and CEO Travere Therapeutics

James Gillespie President Center for Healthcare Innovation

James Gillespie

President Center for Healthcare Innovation

Teresa Graham CEO Roche Genentech

Teresa Graham

CEO Roche Genentech

Teresa Graham is Head of Global Product Strategy and member of the Pharma Leadership Team. Teresa joined Genentech in 2005 and has led teams across life-cycle management, access, marketing and commercial in the US and globally. Prior to her current role, she served as Lifecycle Leader and Vice President for Rheumatology and Bio-Oncology Sales and Marketing in the US. Teresa is passionate about working in partnerships and co-creating integrated solutions to accelerate innovation and access. She has been an active participant in a number of women’s organisations for a long time now, and is very active in mentoring and coaching programmes. Teresa has a degree from The George Washington University, Washington D.C., USA.

Otis Johnson Principal Consultant Trial Equity

Otis Johnson

Principal Consultant Trial Equity

Dr. Otis Johnson is the Founder of Trial Equity, whose purpose is to ensure that medicines are safe and effective for all people by providing solutions for diverse patient recruitment in clinical trials. Recognized for his leadership by Pharmavoice, Informa Connect and Mogul, he has served on the diversity advisory boards of the Association of Clinical Research Organizations (ACRO) and the Association of Clinical Research Professionals (ACRP). He is also on the advisory board of Wake Forest University’s Master’s Degree Program in Clinical Research Management.

Michelle Keefe Board of Directors

Michelle Keefe

Board of Directors

Michelle is a global life sciences executive with 30+ years of commercial and clinical Go to Market, operational and financial expertise, and a proven track record of creating cross-collaborative, agile teams that accelerate product development success. She leads with a strong strategic focus to deliver growth and long-term value for shareholders, customers, employees and communities, in existing, start–up and acquisition environments. She joined Syneos Health® in 2017 and serves as President, Commercial Solutions, with leadership oversight of an insights-driven multi-disciplinary commercial organization including Deployment Solutions, Communications, and Consulting. This team delivers innovative, integrated solutions including accelerated patient clinical trial recruitment and optimized brand launch. Syneos Health brings together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Previous to Syneos Health, Michelle held leadership positions at Publicis, The Visiting Nurse Service of New York and Pfizer.  A champion for inclusive, collaborative cultures, Michelle is an Executive sponsor of the Syneos Health Women’s Group, Diversity, Equity & Inclusion Council and Syneos Heath Rising Star and Luminary employee recognition program. Throughout her career she’s held a steadfast commitment to developing and guiding others, serving on HBA’s Metro Chapter’s advisory board 2013-2017 and mentoring in the HBA mentorship program 2015-2017. Michelle received her B.S. Marketing from Seton Hall University, NJ, and completed coursework at Wharton Aresty Institute of Executive Education and PDI Ninth House General Management Assessment Center 2012 (now Korn Ferry).

Reshema Kemps-Polanco Executive Vice President & Chief Commercial Officer

Reshema Kemps-Polanco

Executive Vice President & Chief Commercial Officer

Simona King Chief Financial Officer Aurora Cannabis

Simona King

Chief Financial Officer Aurora Cannabis

Simona is a strategic leader with over 20 years of diverse finance and business experience in the pharmaceutical industry. Simona is currently EVP and Chief Financial Officer at Tmunity, a cell and gene therapy biotech. Prior to that she was at Emergent BioSolutions, as vice president, finance and assistant treasurer, overseeing the financial planning and analysis and treasury organizations, and helped raise $450M in capital financing. Before joining Emergent BioSolutions, Simona spent 19 years at Bristol-Myers Squibb (BMS) most recently as executive director, head of global corporate financial planning and analysis. She started her career with BMS in 2000, and has consistently demonstrated strong leadership in a variety of finance roles of increasing responsibility within global manufacturing, mergers and acquisitions, research & development, enterprise services and US pharmaceuticals, as finance lead for the cardiovascular, neuroscience, diabetes and Puerto Rico businesses. Simona also worked at the board of governors of the Federal Reserve in Washington, DC and in banking in South Africa. Simona serves as vice-chair on the global board of directors of the Healthcare Businesswomen’s Association (HBA). She has a BA in economics from Kalamazoo College, an MBA in finance from Columbia University, a Diploma in African Studies from the University of Cape Town and is a certified public accountant. Originally from Romania, Simona resides in Bethesda, MD with her husband, three active children and family dog. She enjoys travel, beach, exercise and family time.

Rae Livingston Chief Equity Officer AbbVie Inc.

Rae Livingston

Chief Equity Officer AbbVie Inc.

Rae Livingston serves as AbbVie’s Chief Equity Officer. In this role, she leads company-wide efforts to address the issues of race, equality and diversity – both inside and outside of AbbVie. She previously served as Vice President, Business Human Resources, Corporate Functions and U.S. Employee Relations since she joined AbbVie in 2016. Prior to joining AbbVie, Ms. Livingston held several positions of increasing global responsibility with Rockwell Automation, where she most recently served as the vice president of human resources for headquarters functions, culture of inclusion and mergers and acquisitions. She also gained key experience in business human resources and mergers & acquisitions with Medtronic, Inc. and JP Morgan Chase, both in the United States and abroad. Ms. Livingston has served as board chair for the YWCA of Southeast Wisconsin and as a member of the executive committee. In 2021, she was recognized by Diversity Woman Media’s Elite 100 list, as one of a hundred extraordinary Black women executives changing the face of corporate America. She earned her bachelor’s and master’s degrees in business administration from Florida Agricultural and Mechanical University and is a certified senior professional in human resources (SPHR).

Hayden Majajas Global Head of DE&I Takeda Pharmaceuticals, Inc.

Hayden Majajas

Global Head of DE&I Takeda Pharmaceuticals, Inc.

Christine Miller President & Chief Executive Officer Melinta Therapeutics

Christine Miller

President & Chief Executive Officer Melinta Therapeutics

Mara Molinello Senior Vice President - Head of US Region Alnylam Pharmaceuticals, Inc.

Mara Molinello

Senior Vice President - Head of US Region Alnylam Pharmaceuticals, Inc.

Kinnari Patel President, Head of R&D & COO Rocket Pharmaceuticals

Kinnari Patel

President, Head of R&D & COO Rocket Pharmaceuticals

Gisela Paulsen Chief Operating Officer Harbinger Health, A Flagship Pioneering Company

Gisela Paulsen

Chief Operating Officer Harbinger Health, A Flagship Pioneering Company

Gisela Paulsen is Chief Operating Officer at Harbinger Health, a Flagship Pioneering Company. Paulsen has over two decades of experience as a cross-functional leader, with an extensive scientific and operational background leading large-scale global change management and driving commercial and drug development innovation at global pharmaceutical and diagnostics companies. Prior to joining Harbinger Health, Paulsen was most recently Chief Operating Officer of Oncocyte Corporation.. She has also held senior roles at Roche/Genentech, where she was ultimately responsible for oversight of Global Clinical Operations for Roche Product Development and led a 3,000-member global workforce after spending over 15 years at the company in various divisions spanning oncology marketing, commercial compliance, patient access, product development and clinical operations. Before her time at Roche/Genentech, Paulsen was a General Manager at Health Learning Systems, the founding medical education unit of Ogilvy. Paulsen is currently an Entrepreneur in Residence at DigitalDX Ventures. Paulsen has served on the HBA Board of Directors since 2019 and leads the HBA’s Digital Transformation Initiative improving the member experience and global community connectivity.

Pamela Puryear EVP, Global Chief Human Resources Officer Walgreens Boots Alliance

Pamela Puryear

EVP, Global Chief Human Resources Officer Walgreens Boots Alliance

Kathrin Schoenborn Advisor & Investor, Non-Executive Director; HBA 2024 STAR

Kathrin Schoenborn

Advisor & Investor, Non-Executive Director; HBA 2024 STAR

Kathrin is a healthcare veteran with over 3 decades of global leadership experience in strategic and business operations roles focused around innovation and pipeline progress. She is recognized as a strategy builder and implementer, dynamic and inspiring leader and change architect, thriving in a surrounding where change is the norm. Since 2022 she enjoys a portfolio career, as investor, startup advisor, board director, mentor and coach. Before she was VP in R&D Operations in the Healthcare business of Merck KGaA, Darmstadt, Germany, after various global leadership positions in Project Leadership, Business Development, Strategic Innovation, and Clinical Operations. Prior to joining Merck KGaA she worked with SANDOZ (now Novartis) and in public pharmacies; she is a pharmacist with PhD from Bonn University. Kathrin is purpose driven and people oriented with a passion for developing talent and driving gender equality and diversity. In 2010 she co-founded the HBA Frankfurt chapter and led its growth to a thriving community. Since 2014 she was active in various volunteer leadership roles at the HBA Europe regional level, between 2018 and 2021 as Chair. Under her leadership Europe evolved to the HBA’s region of most growth, which was recognized with the HBA Regional Excellence Award 2021.

Erik Smith Principal, Strategy & Analytics, Life Sciences Deloitte LLP

Erik Smith

Principal, Strategy & Analytics, Life Sciences Deloitte LLP

Erik D. Smith, Ph.D. is a Principal with Deloitte Consulting’s Strategy Practice. For over 15 years, he’s worked across health care, including manufacturers, payers, providers and others in the space – both in the US and around the world. The majority of Erik’s work has focused on the commercial side of bio-pharma, covering corporate, BU, franchise, product and country levels, across numerous therapeutic areas, asset and product stages. Erik has delivered new strategies and tested those already in use, for clients at all levels, including Boards. He’s launched innovation initiatives, and updated risk management programs. Erik brings particular expertise in understanding uncertainty, both for long-term strategy and for short-term tactics. He’s an advanced user of scenario planning and other simulation approaches, has published on the subject, and taught training courses. With HBA, Erik has served on the Advisory Board of the San Francisco Bay Area Chapter, and more recently on the Advisory Board for the West Region as well as the Strategic Alliances Committee for the Board. Erik holds both a Ph.D. in demography and an M.A. in socio-cultural anthropology from University of California. Berkeley, and a B.A. in political science, with minors in social ecology and philosophy, from UC Irvine.

Susan Torroella Chief Executive Officer ProgenyHealth, LLC

Susan Torroella

Chief Executive Officer ProgenyHealth, LLC

Jim Weiss Founder & Chairman Real Chemistry

Jim Weiss

Founder & Chairman Real Chemistry

{1}

##LOC[OK]##

{1}

##LOC[OK]## ##LOC[Cancel]##

{1}

##LOC[OK]## ##LOC[Cancel]##